Filing Details
- Accession Number:
- 0001209191-14-070401
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-20 17:43:10
- Reporting Period:
- 2014-11-19
- Filing Date:
- 2014-11-20
- Accepted Time:
- 2014-11-20 17:43:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1516479 | Insys Therapeutics Inc. | INSY | Pharmaceutical Preparations (2834) | 510327886 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1235637 | Patrick Fourteau | C/O Insys Therapeutics, Inc. 444 South Ellis Street Chandler AZ 85224 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-11-19 | 25,000 | $39.11 | 80,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The weighted average sales price for the transaction reported was $39.1069, and the range of prices were between $38.71 to $39.50.
Billionaire Hedge Funds
